USA flag logo/image

An Official Website of the United States Government

Improved Formulations to Enhance Bio-availability for Antisense Therapeutics

Award Information

Agency:
Department of Defense
Branch:
Office for Chemical and Biological Defense
Award ID:
96627
Program Year/Program:
2010 / SBIR
Agency Tracking Number:
C101-102-0079
Solicitation Year:
N/A
Solicitation Topic Code:
CBD 10-102
Solicitation Number:
N/A
Small Business Information
LNKCHEMSOLUTIONS
4701 INNOVATION DRIVE LINCOLN, NE -
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 1
Fiscal Year: 2010
Title: Improved Formulations to Enhance Bio-availability for Antisense Therapeutics
Agency / Branch: DOD / CBD
Contract: HDTRA1-10-P-0041
Award Amount: $70,000.00
 

Abstract:

In general, many biological and chemical agents affect the lungs directly or indirectly, even if the respiratory system is not the primary target organ of a military or terrorist attack. Both in the case of military and civilian attacks the lung can be one of the first organs affected by a chemical or biological agent. LNK Chemsolutions (LNK) with expertise in nanoparticle formulations and the University of Illinois Chicago with expertise in Acute Lung Injury (ALI) molecular biology and treatment modality development have teamed up to develop novel oral and inhalation formulation of targeted nanoparticles (NPs) containing siRNA and/or miRNA to improve the treatment of ALI unobtainable with current delivery systems.

Principal Investigator:

Luis Nunez
Chief Technology Officers
6308548173
luisteo@aol.com

Business Contact:

Gus Larsen
CEO
4024161811
lnkchemsolutions@aim.com
Small Business Information at Submission:

LNK Chemsolutions, LLC
4701 Innovation Drive Lincoln, NE 68521

EIN/Tax ID: 470833036
DUNS: N/A
Number of Employees:
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No